Lv6
2430 积分 2023-10-01 加入
Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial
16天前
已完结
Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
3个月前
已完结
Safety and efficacy of chimeric antigen receptor T cells modified to target mesothelin and express PD-1 antibodies in patients with relapsed/refractory solid cancers in a phase I trial
4个月前
已关闭
Risk-Based Screening for Cancer in Patients With Dermatomyositis
9个月前
已完结
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
9个月前
已完结
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
10个月前
已完结
Current use and outcomes of hematopoietic stem cell transplantation: Brazilian summary slides
11个月前
已完结
A novel risk model for predicting early relapse in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem-cell transplantation
11个月前
已完结
Profiling pharmacokinetics of double‐negative T cells and cytokines via a single intravenous administration in NSG mice
11个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
11个月前
已完结
皖公网安备34019202002308
